PLIANT THERAPEUTICS, INC. (PLRX) › Operating Cash FlowPLIANT THERAPEUTICS, INC. (PLRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$2.75M2020: -$37.27M2021: -$75.44M2022: -$94.63M2023: -$116.36M2024: -$155.50M2025: -$128.34M-$128.34M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$128.34M+17.5%2024-$155.50M-33.6%2023-$116.36M-23.0%2022-$94.63M-25.4%2021-$75.44M-102.4%2020-$37.27M-1255.3%2019-$2.75M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share